DocCheck AG (DE:AJ91)
XETRA:AJ91
Want to see DE:AJ91 full AI Analyst Report?
AJ91 Stock Chart & Stats
€12.60
€0.00(0.00%)
At close: 4:00 PM EST
€12.60
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€9.80 - €13.80
Previous CloseN/A
Volume200.00
Average Volume (3M)1.04K
Market Cap
€63.93M
Enterprise Value€53.61M
Total Cash (Recent Filing)€18.54M
Total Debt (Recent Filing)€4.16M
Price to Earnings (P/E)11.7
Beta0.63
Next Earnings
Aug 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield6.36%
Share Statistics
EPS (TTM)0.57
Shares Outstanding5,073,816
10 Day Avg. Volume577
30 Day Avg. Volume1,041
Financial Highlights & Ratios
PEG Ratio12.17
Price to Book (P/B)1.50
Price to Sales (P/S)1.13
P/FCF Ratio23.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetDocCheck's low leverage and sizeable equity position provide durable financial flexibility. A debt-to-equity around 0.10x and a conservative capital base reduce refinancing and solvency risk, enabling the company to fund strategic investments or weather cyclical revenue swings over the next 2–6 months.
Healthy MarginsSustained high‑teens EBITDA and roughly 10% net margins indicate an efficient, service-based cost structure and pricing power in its niche. Margin durability supports cash generation and the ability to invest in product improvements or client services without immediate reliance on top-line growth.
Niche B2B Healthcare NetworkOwning a verified professional healthcare community is a structural competitive advantage: it creates high entry barriers, predictable demand for targeted B2B marketing, and sticky client relationships. This network effect supports recurring revenue and positions the firm defensibly in health‑sector digital services.
Bears Say
Revenue VolatilityVolatile top-line performance, including a clear 2025 decline, undermines predictability for clients and investors. For a services business, inconsistent revenue complicates capacity planning, weakens operating leverage benefits, and raises risk that shortfalls persist rather than revert to prior growth trends.
Free Cash Flow InstabilitySharp swings in free cash flow, including a halving in 2025, reduce the reliability of internally generated funds for dividends, buybacks, or reinvestment. This volatility suggests working capital or reinvestment timing issues that can constrain strategic flexibility during weaker revenue periods.
Normalized Growth And Cooled ProfitabilityReturns and growth have normalized from exceptional earlier years, signaling a tougher growth runway. Even with healthy margins, slower revenue and lower ROE versus peak periods indicate limited operating leverage upside and potential pressure on long‑term EPS growth absent new structural initiatives.
DocCheck AG News
AJ91 FAQ
What was DocCheck AG’s price range in the past 12 months?
DocCheck AG lowest stock price was €9.80 and its highest was €13.80 in the past 12 months.
What is DocCheck AG’s market cap?
DocCheck AG’s market cap is €63.93M.
When is DocCheck AG’s upcoming earnings report date?
DocCheck AG’s upcoming earnings report date is Aug 04, 2026 which is in 98 days.
How were DocCheck AG’s earnings last quarter?
DocCheck AG released its earnings results on Feb 06, 2026. The company reported €0.567 earnings per share for the quarter, beating the consensus estimate of N/A by €0.567.
Is DocCheck AG overvalued?
According to Wall Street analysts DocCheck AG’s price is currently Overvalued.
Does DocCheck AG pay dividends?
DocCheck AG pays a Annually dividend of €0.75 which represents an annual dividend yield of 6.36%. See more information on DocCheck AG dividends here
What is DocCheck AG’s EPS estimate?
DocCheck AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DocCheck AG have?
DocCheck AG has 5,073,816 shares outstanding.
What happened to DocCheck AG’s price movement after its last earnings report?
DocCheck AG reported an EPS of €0.567 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of DocCheck AG?
Currently, no hedge funds are holding shares in DE:AJ91
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DocCheck AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.71%
12-Months-Change
Fundamentals
Return on Equity
13.28%
Trailing 12-Months
Asset Growth
-8.52%
Trailing 12-Months
Company Description
DocCheck AG
DocCheck AG offers marketing, customer relationship management, and e-commerce services for the healthcare sector in Europe. The company operates DocCheck portal for exchanging information on the Internet, and online and e-commerce services for healthcare market players. It also develops and implements communication strategies for new and traditional media on healthcare and business-to-business sectors; and promotes healthcare startups through seed funding. DocCheck AG is based in Cologne, Germany.